2023 SMR Congress Insights: "Study of DYP688, an ADC Delivering a Direct Gq/11 Inhibitor in Patients With Metastatic Uveal Melanoma & Other GNAQ/11 Mutant Melanomas"

140 views
November 24, 2023
Comments 1
Login to view comments. Click here to Login